16 Mar 2021 --- BASF is “exploring possible synergies” with industrial synthetic biotech company Bota Biosciences following BASF Venture Capital (BVC)’s investment of an undisclosed sum. Bota Bio is based in China and is developing a biotechnology platform to produce high-value products sustainably and economically. These products include industrial applications, such as vitamins, sweeteners and personal care.
